CVS Health Corporation · NYSE:CVS
CVS Health — Caremark RX — Merger or Acquisition (March 2007)
20 slides from CVS Health's merger presentation, Mar 13, 2007
Slide 1: Safe Harbor Statement
Safe Harbor Statement During this presentation, we will make certain forward looking statements that are subject to risks and uncertainties that could cause actual results to differ materially. For these statements, we claim the protection of the Safe Harbor for forward-looking statements claimed in
Slide 2: Agenda
Agenda o CVS Leadership o Industry Trends and the CVS Advantage o Drivers of Growth and Profitability o CVS/Caremark Merger
Slide 3: CVS: Leading the Pharmacy Industry
CVS: Leading the Pharmacy Industry o #1 in Store Count ... 6,200 Stores o #1 in Pharmacy Sales ... $31 Billion in 2006 o #1 in Sales Per Retail Square Foot ... $785 o #1 Retail-based Health Provider ... MinuteClinic o #1 Retail Loyalty Program ... ExtraCare o #4 Full-service PBM ... PharmaCare
Slide 4: Industry Trends Driving Profitability
Industry Trends Driving Profitability Aging U.S. o 65+ population will increase 36% to 55mm from 2010-2020 Population o 65+ fill >25 scripts per year, 30% more than those 55-64 Specialty o Fastest growing pharmacy sector Pharmaceuticals 0 New biotech drugs to treat complex illnesses Generic Drug o $
Slide 5: The CVS Advantage
The CVS Advantage o Market Leadership, Filling 16% of U.S. Retail Prescriptions o Convenient Locations and Hours; Shopper-friendly stores o Focus on Health, Beauty and Exclusive Products o MinuteClinic - Pioneer and Leader in U.S. Retail Health Clinics o Rapidly Integrating and Growing Former Sav-on
Slide 6: Financial Performance Highlights
Financial Performance Highlights Dollars millions, except per share figure 2003 2006 CAGR 2007E ---- ---- ---- ----- Total sales $26,588 $43,814 +18.1% +13 to 15% Same store sales +5.8% +8.2% +6 to 8% Pharmacy +8.1% +9.1% Front-end +1.2% +6.2% Operating Profit 1,424 2,401 +19.0% Diluted EPS 1.03 1.5
Slide 7: CVS Rx Market Share Increasing
CVS Rx Market Share Increasing Acquisitions and Organic Growth are the Key o CVS retail market share has increased from 10.7% in 2002 to 16.0% in 2006. 2003 2004 2005 2006 ---- ---- ---- ---- All Chain Stores 1.5% 1.4% 6.5% 10.7% CVS Total Scripts 5.4% 19.6% 13.5% 19.4% Notes: 1. CVS 2004 adjusted t
Slide 8: CVS Commands Leadership in Top U.S. Drugstore Markets
CVS Commands Leadership in Top U.S. Drugstore Markets Market Rank Market CVS Rank 1 New York #1 2 Los Angeles #1 3 Chicago #2 4 Philadelphia #1 5 Detroit #1 6 Miami-Ft. Lauderdale #2 7 Boston #1 8 Dallas-Ft. Worth #2 9 Houston #2 10 Cleveland #2 Source: Chain Drug Review, October 2006
Slide 9: Enhancing our Share in High-Growth Markets
Enhancing our Share in High-Growth Markets New and Acquired Stores 2004-2006 2,411 77% of New Store Openings Have Been in Large and High-growth Markets 1,863 o Providing CVSeasy Access Across the Chain: o >60% of Stores Are Freestanding o 55% of Stores Have Drive-thrus o 65% of Stores Are 24- or Ext
Slide 10: Front End Focus: Health, Beauty and Exclusive Products
Front End Focus: Health, Beauty and Exclusive Products Customers Love Choice, Quality and Value of Health and Beauty Offerings + CVS Brand and Exclusive Products Are 14% of Front-store Sales o Goal of 18% to 20% Over Next Three to Five Years + ExtraCare Loyalty Care Program = FS Comps That Lead the
Slide 11: MinuteClinic Broadens CVS Role in Healthcare
MinuteClinic Broadens CVS Role in Healthcare o Provides Customers With Convenient, Cost-effective, and High-quality Healthcare in a Retail Setting. o 155 Clinics Across 19 States - Most in Nation ... 750K Patient Visits to Date o Plan to Open 300 in 2007. o Well Over 2,500 CVS/pharmacy Stores Slated
Slide 12: The CVS/Caremark Merger is in the Best Interest of Shareholders
The CVS/Caremark Merger is in the Best Interest of Shareholders
Slide 13: CVS/Caremark Merger Enhances Shareholder Value: Offer Terms
CVS/Caremark Merger Enhances Shareholder Value o "Best and Final Offer o 1.67 shares CVS/Caremark stock for each share of CMX o $7.50 special dividend to CMX shareholders of record o Accretive repurchase of 150 million shares at $35 2008E 2009E ----- ----- Free Cash Flow $3.0 Billion + $3.5 Billion
Slide 14: CVS/Caremark Merger Enhances Shareholder Value: Strategic and Financial Benefits
CVS/Caremark Merger Enhances Shareholder Value o Uniquely positioned to capitalize on trends and better serve customers o Will enable creation of differentiated services Strategic Benefits o More effective cost management for payors o More access to information and choice for consumers o $500 M in c
Slide 15: CVS/Caremark Merger Enhances Shareholder Value: Flexibility and Certainty
CVS/Caremark Merger Enhances Shareholder Value o Substantial FCF will enable flexibility for investments in existing business, strategic opportunities, dividends and share repurchases Financial Flexibility o Solid investment grade credit rating 0 Proven track-records with large scale acquisition int
Slide 16: Near-Term Revenue Opportunities Unique to CVS/Caremark Combination
Near-Term Revenue Opportunities Unique to CVS/Caremark Combination o Incremental opportunities of $800 M to $1 B in 2008 o Half from PBM, half from retail o Revenue estimates based on market research and PharmaCare-CVS experience o Revenue synergy examples: o Improved access/services for PBM special
Slide 17: CVS/Caremark Merger is in the Best Interests of Shareholders
CVS/Caremark Merger is in the Best Interests of Shareholders o Immediate and concrete financial benefits o March 2007 close o Significant strategic benefits o Clients supportive o Proven management teams CVS/Caremark Merger ESRX Proposal o Highly conditional offer o Financial benefits suspect o Unce
Slide 18: CVS: Well-positioned Leader in a Growing Industry
CVS: Well-positioned Leader in a Growing Industry o Core Business is Thriving o Gaining Share in Front Store and Pharmacy o Organic Growth o Continued Eckerd Turnaround o Sav-on/Osco Integration Complete ... Opportunity Ahead o MinuteClinic Rollout Broadens Healthcare Role o Retail/PBM Model a Winni
Slide 19: Well-positioned Leader in a Growing Industry
Well-positioned Leader in a Growing Industry Tom Ryan Chairman, President, and CEO March 13, 2007
Slide 20: Certain Information Regarding the Tender Offer After Closing of the Merger
Certain Information Regarding the Tender Offer After Closing of the Merger The information in this document describing CVS’ planned tender offer following closing of the CVS/Caremark merger is for informational purposes only and does not constitute an offer to buy or the solicitation of an offer to